Pratorimine is primarily used in the development of pharmaceutical intermediates, particularly in the synthesis of bioactive molecules with potential antiviral and anticancer properties. Its structural characteristics make it valuable in medicinal chemistry for modifying core scaffolds to enhance drug efficacy and selectivity. It has also been explored as a building block in the creation of novel heterocyclic compounds for use in targeted therapies. Additionally, pratorimine derivatives are investigated for their role in enzyme inhibition, especially in pathways associated with inflammatory responses and tumor progression. Its application extends to research settings where it aids in probing biological mechanisms and developing new therapeutic agents.